Drugs / Plasmid AMEP
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01664273 | Jul 2012 → May 2015 | metastatic malignant neoplasm | Copenhagen University Hospital at Herlev | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Plasmid AMEP | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01664273 ↗ |
| Route | Intramuscular | “Plasmid AMEP is injected intramuscularly” NCT01664273 ↗ |